Srikanth Singamsetty

Phoenix Nest, Inc.

NIH Rank #6590
  • Early Career

NIH Funding · FY2024

Total Funding
$1.8M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#6,590
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.8M across 3 grants · National rank #6590.

Top grants by award amount

Srikanth Singamsetty's NIH grant portfolio, ranked by award amount.

  • 1R44NS137892-01R44
    Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients.
    $881.7K
    award amount
  • 5UB1NS122644-04UB1
    Evaluation of Clinical Outcome Assessment (COA) and Potential Biomarkers to Facilitate Interventional Trial for Mucopolysaccharidosis IIID Patients
    $798.3K
    award amount
  • 3UB1NS122644-04S1UB1
    Evaluation of Clinical Outcome Assessment (COA) and Potential Biomarkers to Facilitate Interventional Trial for Mucopolysaccharidosis IIID Patients
    $100K
    award amount

Affiliation

Institutions that have administered grants for Srikanth Singamsetty.

Affiliated with Phoenix Nest, Inc. (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Phoenix Nest, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6590